OAC
OMERS Administration Corp Portfolio holdings
AUM
$12.7B
1-Year Return
22.78%
This Quarter Return
-2.69%
1 Year Return
+22.78%
3 Year Return
+71.29%
5 Year Return
+144.31%
10 Year Return
+293.75%
AUM
$11.4B
AUM Growth
-$5.94M
(-0.05%)
Cap. Flow
+$480M
Cap. Flow
% of AUM
4.2%
Top 10 Holdings %
Top 10 Hldgs %
33.97%
Holding
1,167
New
212
Increased
341
Reduced
392
Closed
141
Top Buys
| 1 |
Eaton
ETN
|
+$112M |
| 2 |
Salesforce
CRM
|
+$112M |
| 3 |
Duke Energy
DUK
|
+$105M |
| 4 |
Eli Lilly
LLY
|
+$99.8M |
| 5 |
Toronto Dominion Bank
TD
|
+$75.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$135M |
| 2 |
Exxon Mobil
XOM
|
+$111M |
| 3 |
Elevance Health
ELV
|
+$53.1M |
| 4 |
TJX Companies
TJX
|
+$42.1M |
| 5 |
ServiceNow
NOW
|
+$30.5M |
Sector Composition
| 1 | Technology | 24.87% |
| 2 | Financials | 19.66% |
| 3 | Industrials | 11.21% |
| 4 | Healthcare | 9.16% |
| 5 | Consumer Discretionary | 7.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Tiziana Life Sciences
TLSA
$213M
| $156K | ﹤0.01% |
+144,900
| New | +$156K |
|
952
Palladyne AI
PDYN
$295M
| $156K | ﹤0.01% |
26,600
+2,100
| +9% | +$12.3K |
|
|
STKL
953
SunOpta
STKL
$755M
| $156K | ﹤0.01% |
+32,000
| New | +$156K |
|
954
uniQure
QURE
$953M
| $152K | ﹤0.01% |
+14,300
| New | +$152K |
|
955
Citizens
CIA
$265M
| $149K | ﹤0.01% |
32,800
+17,064
| +108% | +$77.6K |
|
956
Cleveland-Cliffs
CLF
$5.53B
| $145K | ﹤0.01% |
17,607
-91,400
| -84% | -$751K |
|
957
Western New England Bancorp
WNEB
$250M
| $142K | ﹤0.01% |
+15,300
| New | +$142K |
|
958
CION Investment
CION
$527M
| $142K | ﹤0.01% |
+13,700
| New | +$142K |
|
959
Atomera
ATOM
$108M
| $137K | ﹤0.01% |
34,200
-13,600
| -28% | -$54.4K |
|
960
Sangamo Therapeutics
SGMO
$160M
| $136K | ﹤0.01% |
207,800
+100,500
| +94% | +$65.9K |
|
|
SERV
961
Serve Robotics
SERV
$687M
| $135K | ﹤0.01% |
23,500
-8,400
| -26% | -$48.3K |
|
962
HighPeak Energy
HPK
$925M
| $134K | ﹤0.01% |
+10,600
| New | +$134K |
|
963
Accel Entertainment
ACEL
$931M
| $134K | ﹤0.01% |
+13,500
| New | +$134K |
|
964
Gerdau
GGB
$6.25B
| $129K | ﹤0.01% |
45,587
| – | – |
|
965
Seer Inc
SEER
$117M
| $129K | ﹤0.01% |
76,200
+26,819
| +54% | +$45.3K |
|
|
SRG
966
Seritage Growth Properties
SRG
$253M
| $127K | ﹤0.01% |
+39,200
| New | +$127K |
|
|
BZAI
967
Blaize Holdings, Inc. Common Stock
BZAI
$362M
| $123K | ﹤0.01% |
+61,000
| New | +$123K |
|
968
Inhibikase Therapeutics
IKT
$122M
| $123K | ﹤0.01% |
56,000
+1,400
| +3% | +$3.07K |
|
969
UiPath
PATH
$6.34B
| $119K | ﹤0.01% |
11,537
-1,906
| -14% | -$19.6K |
|
|
INV
970
Innventure, Inc. Common Stock
INV
$313M
| $116K | ﹤0.01% |
+15,100
| New | +$116K |
|
971
DHI Group
DHX
$140M
| $105K | ﹤0.01% |
+75,272
| New | +$105K |
|
972
Vor Biopharma
VOR
$238M
| $100K | ﹤0.01% |
+139,600
| New | +$100K |
|
973
Alliance Entertainment
AENT
$310M
| $93.5K | ﹤0.01% |
27,900
+17,900
| +179% | +$60K |
|
974
Champions Oncology
CSBR
$92.9M
| $92.9K | ﹤0.01% |
+10,700
| New | +$92.9K |
|
975
DiaMedica Therapeutics
DMAC
$382M
| $92.1K | ﹤0.01% |
24,300
+1,800
| +8% | +$6.82K |
|